et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark and Finland. N. Engl. J. Med.
343, 78–85 (2000).
Stratton, J.F., Pharoah, P., Smith, S.K., Easton, D. & Ponder, B.A.
A systematic review and meta-analysis of family history and risk of ovarian cancer. Br. J. Obstet. Gynaecol.
105, 493–499 (1998).
Antoniou, A.C. & Easton, D.F.
Risk prediction models for familial breast cancer. Future Oncol.
2, 257–274 (2006).
et al. A genome-wide association study identifies a new ovarian cancer susceptibility l ocus on 9p22.2. Nat. Genet.
41, 996–1000 (2009).
et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet.
42, 880–884 (2010).
et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet.
42, 874–879 (2010).
et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat. Comm. published online; doi:10.1038/ncomms2629 (27 March 2013).
et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature
473, 43–49 (2011).
et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet.
5, e1000597 (2009).
et al. Functional characterization of liver enhancers that regulate drug-associated transporters. Clin. Pharmacol. Ther.
89, 571–578 (2011).
Wasserman, N.F., Aneas, I. & Nobrega, M.A.
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res.
20, 1191–1197 (2010).
Wright, J.B., Brown, S.J. & Cole, M.D.
Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell Biol.
30, 1411–1420 (2010).
McCullough, J., Fisher, R.D., Whitby, F.G., Sundquist, W.I. & Hill, C.P.
ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl. Acad. Sci. USA
105, 7687–7691 (2008).
Carlton, J.G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J.
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science
336, 220–225 (2012).
Yu, X., Riley, T. & Levine, A.J.
The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J.
276, 2201–2212 (2009).
et al. Genome-wide gene expression profiles of ovarian carcinoma: identification of molecular targets for the treatment of ovarian carcinoma. Mol. Med. Report
2, 365–384 (2009).
Caudell, D. & Aplan, P.D.
The role of CALM-AF10 gene fusion in acute leukemia. Leukemia
22, 678–685 (2008).
et al. Nebulette is the second member of the nebulin family fused to the MLL gene in infant leukemia. Cancer Genet. Cytogenet.
198, 151–154 (2010).
Ram, R. & Blaxall, B.C.
Nebulette mutations in cardiac remodeling: big effects from a small mechanosensor. J. Am. Coll. Cardiol.
56, 1503–1505 (2010).
et al. ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma. PLoS Biol.
9, e1001156 (2011).
et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet.
42, 579–589 (2010).
et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat. Genet.
43, 451–454 (2011).
et al. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS ONE
5, e10858 (2010).
Kato, N., Sasou, S. & Motoyama, T.
Expression of hepatocyte nuclear factor-1β (HNF-1β) in clear cell tumors and endometriosis of the ovary. Mod. Pathol.
19, 83–89 (2006).
et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am. J. Pathol.
163, 2503–2512 (2003).
Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature
474, 609–615 (2011).
Kato, N. & Motoyama, T.
Hepatocyte nuclear factor-1β (HNF-1β) in human urogenital organs: its expression and role in embryogenesis and tumorigenesis. Histol. Histopathol.
24, 1479–1486 (2009).
Hindorff, L.A., Junkins, H.A., Hall, P.A., Mehta, J.P. & Manolio, T.A.
A catalogue of published genome-wide association studies. Genome.gov: National Institutes of Health National Human Genome Research Institute. <http://www.genome.gov/gwastudies/> (2013).
et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet.
42, 885–892 (2010).
et al. Large-scale genotyping identifies 41 new breast cancer susceptibility loci. Nat. Genet. published online; doi:10.1038/ng.2563 (27 March 2013).
et al. Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia
12, 317–325 (2010).
et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res.
71, 3896–3903 (2011).
Artificial intelligence and global normalization methods for genotyping. US patent 7,035,740 (2008).
et al. A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics
23, 2741–2746 (2007).
Giannoulatou, E., Yau, C., Colella, S., Ragoussis, J. & Holmes, C.C.
GenoSNP: a variational Bayes within-sample SNP genotyping algorithm that does not require a reference population. Bioinformatics
24, 2209–2214 (2008).
Sankararaman, S., Sridhar, S., Kimmel, G. & Halperin, E.
Estimating local ancestry in admixed populations. Am. J. Hum. Genet.
82, 290–303 (2008).
et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet.
38, 904–909 (2006).
Xing, G., Lin, C.Y., Wooding, S.P. & Xing, C.
Blindly using Wald's test can miss rare disease-causal variants in case-control association studies. Ann. Hum. Genet.
76, 168–177 (2012).
Breslow, N.E. & Day, N.E.
Statistical Methods in Cancer Research. Volume 1—The Analysis of Case-Control Studies (International Agency for Research on Cancer, Lyon, 1980).
et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res.
39, D945–D950 (2011).
Mostafavi, S., Ray, D., Warde-Farley, D., Grouios, C. & Morris, Q.
GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol.
9 (suppl. 1), S4 (2008).
et al. Histone modifications at human enhancers reflect global cell-type–specific gene expression. Nature
459, 108–112 (2009).